Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
A.H.E. Roukens en L.G. Visser is a professional medical partnership based in Leiden, Netherlands, specializing in infectious diseases, vaccinology, and travel medicine. The entity is led by Dr. Anna Roukens and Professor Leo Visser, both of whom are highly regarded clinical researchers affiliated with the Leiden University Medical Center (LUMC). The partnership is primarily known for conducting investigator-initiated clinical trials that focus on optimizing vaccine administration, such as dose-sparing strategies and intradermal delivery techniques. Their research has significantly impacted international guidelines for yellow fever and rabies vaccinations. They operate as a specialized clinical research unit within the academic framework of the LUMC, providing expertise in tropical medicine and immunization protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on A.H.E. Roukens en L.G. Visser.